tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BIOA Stock Latest News

BioAge Labs initiated with an Overweight at Piper Sandler
The FlyBioAge Labs initiated with an Overweight at Piper Sandler
6d ago
BIOA
BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating
PremiumRatings
BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating
6d ago
BIOA
BioAge Labs Announces Upsized Public Equity Offering
PremiumCompany Announcements
BioAge Labs Announces Upsized Public Equity Offering
11d ago
8K
BIOA
Closing Bell Movers: Netflix down 5% after soft guidance
PremiumThe Fly
Closing Bell Movers: Netflix down 5% after soft guidance
13d ago
HWC
OZK
BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating
PremiumRatings
BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating
13d ago
BIOA
BioAge Labs announces $75M common stock offering
PremiumThe FlyBioAge Labs announces $75M common stock offering
13d ago
BIOA
BioAge Labs management to meet with Piper Sandler
Premium
The Fly
BioAge Labs management to meet with Piper Sandler
13d ago
BIOA
BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines
Premium
Ratings
BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines
13d ago
BIOA
BioAge Labs advances BGE-102 into ophthalmology clinical trials
PremiumCompany Announcements
BioAge Labs advances BGE-102 into ophthalmology clinical trials
13d ago
8K
BIOA
BioAge Labs announces expansion of its BGE-102 development program
PremiumThe Fly
BioAge Labs announces expansion of its BGE-102 development program
13d ago
BIOA
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/16/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/16/26
17d ago
CLB
MSS
Vanguard Total Stock Market ETF (VTI) Daily Update—1/15/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Update—1/15/26
18d ago
CLB
MSS
BioAge Labs: Early-Stage NLRP3-Targeting Promise with Encouraging hsCRP Data, but Balanced Risk-Reward Supports Hold
PremiumRatingsBioAge Labs: Early-Stage NLRP3-Targeting Promise with Encouraging hsCRP Data, but Balanced Risk-Reward Supports Hold
20d ago
BIOA
BioAge Labs advances BGE-102 with strong Phase 1 data
Premium
Company Announcements
BioAge Labs advances BGE-102 with strong Phase 1 data
21d ago
8K
BIOA
BioAge Labs announces additional interim data from Phase 1 trial of BGE-102
Premium
The Fly
BioAge Labs announces additional interim data from Phase 1 trial of BGE-102
21d ago
BIOA
BioAge Labs upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
BioAge Labs upgraded to Equal Weight from Underweight at Morgan Stanley
2M ago
BIOA
Positive Developments and Promising Trials Bolster Buy Rating for BioAge Labs
PremiumRatings
Positive Developments and Promising Trials Bolster Buy Rating for BioAge Labs
2M ago
BIOA
BioAge Labs Announces Positive Phase 1 Trial Results
PremiumCompany Announcements
BioAge Labs Announces Positive Phase 1 Trial Results
2M ago
8K
BIOA
BioAge Labs announces interim Phase 1 data for BGE-102
PremiumThe Fly
BioAge Labs announces interim Phase 1 data for BGE-102
2M ago
BIOA
BioAge Labs Advances Clinical Programs Amid Financial Progress
PremiumCompany AnnouncementsBioAge Labs Advances Clinical Programs Amid Financial Progress
3M ago
BIOA
BioAge Labs price target raised to $15 from $10 at Citi
Premium
The Fly
BioAge Labs price target raised to $15 from $10 at Citi
3M ago
BIOA
Citi upgrades BioAge Labs to Buy on potential in obesity
Premium
The Fly
Citi upgrades BioAge Labs to Buy on potential in obesity
3M ago
BIOA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >